Steve Cohen Periodic Transaction Report

Filed Jan 10, 2025 · House Clerk · 2 transactions

U.S. Representative · D · TN-09 · All trades by Steve Cohen

On January 10, 2025, Rep. Steve Cohen (D-TN-09) filed a periodic transaction report with the House Clerk disclosing 2 transactions (2 sales) dated Dec 11, 2024.

The filing covers 2 tickers, including $EBS, $HST.

Reported amount ranges sum to $16K–$65K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 30 days.

Source document: House Clerk filing 20026548

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Steve Cohen · Sold $HST · Dec 11 · $15K–$50K

0.42LOW

Disclosure speedx 0.250.10

Trade sizex 0.250.50

Cluster activityx 0.150.00

Track recordx 0.350.77

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Steve Cohen

Get an email the moment Steve Cohen files the next one. Free, no card, no spam.

Follow free →

Transactions

0 / 2

Buys / sells

Tickers

30d

Longest lag

Tickers in this filing

EBS1 HST1

Transactions disclosed

Trade date	Ticker	Asset	Type	Owner	Amount	Lag
Dec 11, 2024	EBS	Emergent BioSolutions Inc. Common Stock (EBS)	sell	—	$1K–$15K	30d
Dec 11, 2024	HST	Host Hotels & Resorts, Inc. - Common Stock (HST)	sell	—	$15K–$50K	30d

Other recent filings by Steve Cohen

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →